Evaluation of quality of life in patients receiving treatment for advanced breast cancer.
Linear analogue self-assessment was used to measure the subjective effects of treatment in women with advanced breast cancer. The results show that this technique may be used to monitor the subjective benefit of treatment and to compare the subjective toxicities of different therapeutic regimens. The results also suggest that the subjective toxicity of cytotoxic therapy is not related to the patient's age and diminishes with successive courses of drugs.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D001943:Breast Neoplasms / Q000188:drug therapy*; D003256:Community Participation; D003258:Consumer Behavior; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D010684:Philosophy; D011788:Quality of Life; D012649:Self Concept; D012647:Self-Assessment; D011795:Surveys and Questionnaires; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil